LMO1 is a novel oncogene in lung cancer, and its overexpression is a new predictive marker for anti-EGFR therapy

Full description

Bibliographic Details

Published in:	Medical oncology. - Springer US, 1984. - 31(2014), 8 vom: 19. Juli
Main Author:	Zhang, Yue (Author)
Other Authors:	Yang, Jili (Author) Wang, Jun (Author) Guo, Huaiyu (Author) Jing, Niancai (Author)
Format:	electronic Article
Language:	English
Published:	2014
ISSN:	1559-131X
External Sources:	lizenzpflichtig